Related references
Note: Only part of the references are listed.Choline metabolism provides novel insights into nonalcoholic fatty liver disease and its progression
Karen D. Corbin et al.
CURRENT OPINION IN GASTROENTEROLOGY (2012)
Disruption of phospholipid and bile acid homeostasis in mice with nonalcoholic steatohepatitis
Naoki Tanaka et al.
HEPATOLOGY (2012)
The cellular and signaling networks linking the immune system and metabolism in disease
Olivia Osborn et al.
NATURE MEDICINE (2012)
Lysophosphatidylcholine enhances the suppressive function of human naturally occurring regulatory T cells through TGF-β production
Hitoshi Hasegawa et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
The Metabolically Benign and Malignant Fatty Liver
Norbert Stefan et al.
DIABETES (2011)
Intrahepatic and intramyocellular lipids are determinants of insulin resistance in prepubertal children
D. E. Larson-Meyer et al.
DIABETOLOGIA (2011)
Aberrant lipid metabolism disrupts calcium homeostasis causing liver endoplasmic reticulum stress in obesity
Suneng Fu et al.
NATURE (2011)
Metabolite profiles and the risk of developing diabetes
Thomas J. Wang et al.
NATURE MEDICINE (2011)
Foxp3 Expression in Liver Correlates with the Degree but Not the Cause of Inflammation
Matthaios Speletas et al.
MEDIATORS OF INFLAMMATION (2011)
Human Fatty Liver Disease: Old Questions and New Insights
Jonathan C. Cohen et al.
SCIENCE (2011)
Metabolism and atherogenic disease association of lysophosphatidylcholine
Gerd Schmitz et al.
ATHEROSCLEROSIS (2010)
Dissociation Between Intrahepatic Triglyceride Content and Insulin Resistance in Familial Hypobetalipoproteinemia
Anastassia Amaro et al.
GASTROENTEROLOGY (2010)
Follow-up Whole-Body Assessment of Adipose Tissue Compartments during a Lifestyle Intervention in a Large Cohort at Increased Risk for Type 2 Diabetes
Juergen Machann et al.
RADIOLOGY (2010)
Mechanisms of impaired regulation by CD4+CD25+FOXP3+ regulatory T cells in human autoimmune diseases
Jane Hoyt Buckner
NATURE REVIEWS IMMUNOLOGY (2010)
A Branched-Chain Amino Acid-Related Metabolic Signature that Differentiates Obese and Lean Humans and Contributes to Insulin Resistance
Christopher B. Newgard et al.
CELL METABOLISM (2009)
Dissociation Between Fatty Liver and Insulin Resistance in Humans Carrying a Variant of the Patatin-Like Phospholipase 3 Gene
Konstantinos Kantartzis et al.
DIABETES (2009)
Viewpoints on the Way to a Consensus Session Where does insulin resistance start? The liver
Gianluca Perseghin
DIABETES CARE (2009)
Relationships Between Circulating Metabolic Intermediates and Insulin Action in Overweight to Obese, Inactive Men and Women
Kim M. Huffman et al.
DIABETES CARE (2009)
High cardiorespiratory fitness is an independent predictor of the reduction in liver fat during a lifestyle intervention in non-alcoholic fatty liver disease
K. Kantartzis et al.
GUT (2009)
Lysophosphatidylcholine Activates Adipocyte Glucose Uptake and Lowers Blood Glucose Levels in Murine Models of Diabetes
Kyungmoo Yea et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity
Elisa Fabbrini et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Identification and characterization of metabolically benign obesity in humans
Norbert Stefan et al.
ARCHIVES OF INTERNAL MEDICINE (2008)
Fatty liver - A novel component of the metabolic syndrome
Anna Kotronen et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Plasma fetuin-A levels and the risk of type 2 diabetes
Norbert Stefan et al.
DIABETES (2008)
Causes and Metabolic Consequences of Fatty Liver
Norbert Stefan et al.
ENDOCRINE REVIEWS (2008)
Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects
Amalia Gastaldelli et al.
GASTROENTEROLOGY (2007)
Mechanisms of Disease: hepatic steatosis in type 2 diabetes - pathogenesis and clinical relevance
Michael Roden
NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM (2006)
Analysis of mass spectral serum profiles for biomarker selection
HW Ressom et al.
BIOINFORMATICS (2005)
Lysophosphatidylcholine modulates neutrophil oxidant production through elevation of cyclic AMP
P Lin et al.
JOURNAL OF IMMUNOLOGY (2005)
Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population
LS Szczepaniak et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2005)
Postabsorptive and insulin-stimulated energy homeostasis and leucine turnover in offspring of type 2 diabetic patients
G Lattuada et al.
DIABETES CARE (2004)
Effects of lysophospholipids on the generation of reactive oxygen species by fMLP- and PMA-stimulated human neutrophils
J Müller et al.
LUMINESCENCE (2002)
Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
JI Cleeman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)